Stockreport

INmune Bio Announces Plan to Submit FDA Biologics License Application (BLA) Seeking Approval of CORDStrom for Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Yahoo! Finance...

INmune Bio Inc. - Common stock  (INMB) 
PDF INmune Bio, Inc. Mon, February 10, 2025 at 1:00 PM GMT+1 10 min read In This Article INMB INmune Bio, Inc. The Company reports results of a double-blinded, [Read more]